MSN Laboratories Tech Stack

Integrated pharma manufacturer with 25 facilities across APIs, finished dosages, and biotech

Pharmaceutical Manufacturing Hyderabad, Telangana State 10,001+ employees Privately Held

MSN Labs operates a vertically integrated pharmaceutical business spanning active pharmaceutical ingredients (APIs), finished dosage formulation, and contract manufacturing services across 25 facilities in India and the USA. The hiring mix—skewed toward quality, regulatory affairs, and manufacturing roles—reflects a company scaling compliance and production capacity rather than pursuing aggressive market expansion. Active projects signal investment in upstream biotech (mammalian and microbial systems, perfusion, single-use platforms) alongside commercial optimization (field force, brand performance, patient analytics), suggesting a shift from generic-first toward specialty therapeutics and patient-centric commercial models.

Tech Stack 10 technologies

Core StackSAP Power BI Excel Zoho HPLC UPLC SDS-PAGE Word PowerPoint Google Sheets

What MSN Laboratories Is Building

◆Challenges

Process improvement in commercial manufacturing
Technology transfer to cmos
Regulatory inspections and audits
Consolidation of books with parent company
Tax compliance
Budgeting and forecasting
Brand strategy
Patient journey analysis
Go-to-market planning
Regulatory process gaps

▲Active Projects

Psurs
Paders
Signal management reports
Upstream process development for mammalian and/or microbial systems
Implement new upstream technologies such as perfusion, single-use systems, pat tools
Digital wellness initiatives
Health screening camps
Patient analytics
Brand performance measurement
Field force optimization initiatives

Hiring Activity

Decelerating20 roles · 4 in 30d

Department

Healthcare

Legal

Quality

Manufacturing

Sales

Finance

Logistics

Marketing

Seniority

Mid

Senior

Director

Junior

Manager

Notable leadership hires: Regulatory Affairs Director

Company intelligence

Find more companies like MSN Laboratories by tech stack, pain points and active projects

Get started free

About MSN Laboratories

MSN Labs is a research-based pharmaceutical manufacturer founded in 2003 and headquartered in Hyderabad, India. The company operates 25 state-of-the-art facilities globally: 17 dedicated to API synthesis and 8 to finished-dosage manufacturing. Its portfolio spans 500+ APIs and 400+ finished-dosage products across 35 major therapeutic areas including oncology, cardiology, CNS, and diabetes, supported by an integrated R&D center. The company reports over 15,000 employees, 900+ patent applications, and presence in more than 100 countries serving approximately 40 million patients. Current hiring emphasizes quality assurance, regulatory affairs, and manufacturing—areas critical to scaling production and navigating multi-country regulatory frameworks—while maintaining a smaller sales and marketing footprint.

HeadquartersHyderabad, Telangana State

Company Size10,001+ employees

Hiring MarketsIndia, Brazil, Philippines, Taiwan, Peru, Colombia, El Salvador, Costa Rica

Frequently Asked Questions

What is MSN Labs' manufacturing footprint?

MSN Labs operates 25 facilities globally: 17 API manufacturing plants and 8 finished-dosage facilities located in India and the USA. The integrated R&D center supports both API and finished-dosage research and development.

What therapeutic areas does MSN Labs cover?

MSN Labs serves 35+ major therapeutic offerings including Oncology, Cardiology, CNS, Diabetes, Nephrology, Urology, Gastroenterology, and Orthopaedics across a portfolio of 500+ APIs and 400+ finished-dosage products.

Is MSN Labs hiring in quality and regulatory roles?

Yes. Quality and regulatory affairs represent the largest active hiring focus: 3 quality roles and 1 Regulatory Affairs Director position are open, reflecting emphasis on manufacturing scale and compliance across multiple geographic markets.